Collagen peptides and whey protein are not interchangeable sources of evidence for muscle outcomes. Both can contribute protein, but their composition and the results of specific human studies differ. A skin or joint claim cannot settle a muscle-building comparison.

The question becomes clearer when the outcome is named. Are we discussing the amount of protein declared on a label, a short-term muscle-protein-synthesis measurement, a change in muscle size, strength or a joint symptom? A study can answer one of these without answering the others.

The Canadian study worth knowing

A 2024 randomized study led by researchers at McMaster University compared whey, pea and collagen supplementation in 31 healthy older men. Participants first consumed a controlled diet, followed by a short supplementation phase. Researchers used isotope methods and muscle biopsies to assess muscle protein synthesis.

Measured synthesis increased during the supplementation phase with whey and pea, while it remained unchanged with collagen under the study conditions. That finding challenges the assumption that all sources of additional protein necessarily produce the same muscle response.

It does not establish a long-term change in strength, disability or muscle size. The groups were small and the observation period was short. The trial also does not compare every commercial powder, mixed formulation or dietary situation.

The Canadian connection is the research setting and investigators, not a special biological rule for Canadian consumers. The study is relevant because it directly compares protein sources and measures a defined human outcome.

What another randomized trial found

A 2020 trial in 22 healthy older women compared whey with collagen peptides over six days, with measurements at rest and after resistance exercise. Whey produced greater increases in the measured muscle-protein-synthesis outcomes.

The paper uses the phrase longer-term for its multi-day measurements. That should not be mistaken for a months-long trial of muscle retention. Duration needs to be stated in ordinary language so the evidence does not acquire a longer horizon in the retelling.

Different populations and experimental designs make the studies complementary, not identical. Neither is an individualized nutrition prescription. The useful message is that the protein source can matter for the outcome being measured.

Muscle connective tissue is not the same endpoint

A 2023 randomized study in 45 young recreational athletes examined responses after a resistance-exercise session. It distinguished myofibrillar protein synthesis from muscle connective protein synthesis. Neither collagen nor whey further increased the connective-protein-synthesis measure during the early recovery period studied.

That narrow finding should not be inflated into a claim that collagen can never affect any connective tissue, nor turned into a promise of tendon healing. It concerns a measured response, in a particular tissue context, over a limited period.

This is why a general statement such as collagen supports connective tissue needs closer inspection. Which tissue? Which outcome? Compared with what? A plausible role for amino acids in the body is not the same as a demonstrated treatment effect from a finished supplement.

Why a protein number is not the whole comparison

The amount of protein and its amino-acid composition are different pieces of information. Equal amounts do not guarantee identical physiological responses. The trials above illustrate why a broad label category cannot substitute for the experimental comparison.

At the same time, this guide does not treat a muscle marker as the only reason anyone might study a protein product. Skin, joint symptoms and other outcomes require their own relevant evidence. The mistake is transferring a finding from one purpose to another.

Our collagen-versus-collagen guide covers hydrolysis, gelatin and form terminology. This page answers the separate whey comparison. The vegan collagen explainer addresses another identity question: whether a builder or biomimetic is actually the same ingredient.

The Canadian label context

The Canadian Food Inspection Agency’s health-claim guidance distinguishes the food framework from natural health products. A label claim needs to be read within the category of the actual product, not borrowed from whichever regulatory system sounds most reassuring.

Health Canada’s hydrolyzed-collagen monograph is an industry guide for natural-health-product licence applications. It explicitly is not a comprehensive review of the ingredient. Finding a claim in an ingredient monograph does not establish that an unrelated retail product was tested against whey or that all possible claims are authorized for it.

We have not evaluated a product’s licence, food label, allergen suitability or compliance. Nor does this article set daily protein targets, recommend supplements or provide a regimen. Individual nutritional needs are a separate assessment.

How to interpret a useful comparison

A well-supported comparison would state whether the tested amounts were comparable, what else participants ate or did, how long they were followed and whether the endpoint was a marker or a functional outcome. It would also identify the exact source and formulation rather than using peptides as a synonym for superior.

The evidence summarized here comes from original published study records and abstracts, not a pooled analysis or complete sponsorship audit. Small samples, short follow-up and selected populations limit how far the findings travel. Those limits remain even when a result is statistically significant.

For broader exercise-claim questions, see our gym-recovery claim checklist. PeptideInfo’s research-reading guide explains study-design differences. The two publications share ownership and offer no sales, prescribing or referral service.

Sources checked October 14, 2026. This is general evidence education, not a personalized diet plan or medical advice. No clinician review has been performed.


Evidence companion: For molecule-specific evidence and Canadian authorization reporting, consult PeptideInfo.ca.

General education only. Source-based reporting, not individualized medical advice or clinician review.